Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-21-000147

Options or other derivatives

  • President and CEO acquired 57,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
White Marvin L President and CEO 2021-01-29 Grant or award · Stock Option (right to buy) +43,125 43,125 D
White Marvin L President and CEO 2021-01-29 Grant or award · Restricted Stock Unit +14,375 14,375 D
Loading xslF345X03/white.xml…